SARS-CoV-2 symptomatic reinfection among patients with primary antibody deficiency

Nufar Marcus1, Liat Ashkenazi-Hoffnung2, Adi Ovadia3

  • 1Allergy and Immunology Unit, Schneider Children's Medical Center of Israel, Felsenstein Medical Research Center, Kipper Institute of Immunology, Petah Tikva, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; The Jeffrey Modell Foundation Israeli Network for Primary Immunodeficiency, New York, NY; Pediatrics B, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.

Abstract

No abstract available in PubMed .

Related Concept Videos